Search Results 251-260 of 8430 for Conduction

  1. A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin amyloidosis - Mayo Clinic

    Current treatment with calcium channel blockers with conduction system effects (e.g., verapamil, diltiazem). The use of dihydropyridine calcium channel ...

  2. Cardiovascular Medicine - Doctors - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

  3. A Study to Evaluate Inflammation of the Heart Muscle Tissue in Patients with Rheumatoid Arthritis - Mayo Clinic

    Irregular heart rhythm (arrhythmia or cardiac conduction abnormality (i.e., atrial fibrillation or flutter, frequentextrasystole, LBBB). Relevant valvular ...

  4. Congenital heart disease in adults - Doctors and departments - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

  5. Cardiovascular Medicine - Doctors - Mayo Clinic

    ... Conduction system disease. Show more areas of focus for Anca Chiriac, M.D., Ph.D. Pagination Doctor search. Go to page 11 · Go to page 22 · NextNext Page. Learn ...

  6. Saline-Enhanced Radiofrequency Catheter Ablation for the Treatment of Ventricular Tachycardia - Mayo Clinic

    Subjects with VTs of septal origin require special care to minimize the risk of heart block, particularly within 2 cm of the AV node/proximal conduction ...

  7. Cardiovascular Medicine - Doctors - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

  8. Cardiovascular Medicine - Doctors - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

  9. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

    ... conduction abnormalities. Patients with history of cardiac disease, such as coronary disease, arrhythmia or congestive heart failure that are on appropriate ...

  10. Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid - Mayo Clinic

    Evidence of any of the following cardiac conduction abnormalities during the screening period: A QTc Fredericia interval >450 milliseconds for males and ...